Pathogenesis of experimental rhesus cytomegalovirus infection
- PMID: 10516066
- PMCID: PMC112992
- DOI: 10.1128/JVI.73.11.9576-9583.1999
Pathogenesis of experimental rhesus cytomegalovirus infection
Abstract
Human cytomegalovirus (HCMV) establishes and maintains a lifelong persistence following infection in an immunocompetent host. The determinants of a stable virus-host relationship are poorly defined. A nonhuman primate model for HCMV was used to investigate virological and host parameters of infection in a healthy host. Juvenile rhesus macaques (Macaca mulatta) were inoculated with rhesus cytomegalovirus (RhCMV), either orally or intravenously (i.v. ), and longitudinally necropsied. None of the animals displayed clinical signs of disease, although hematologic abnormalities were observed intermittently in i.v. inoculated animals. RhCMV DNA was detected transiently in the plasma of all animals at 1 to 2 weeks postinfection (wpi) and in multiple tissues beginning at 2 to 4 wpi. Splenic tissue was the only organ positive for RhCMV DNA in all animals. The location of splenic cells expressing RhCMV immediate-early protein 1 (IE1) in i.v. inoculated animals changed following inoculation. At 4 to 5 wpi, most IE1-positive cells were perifollicular, and at 25 wpi, the majority were located within the red pulp. All animals developed anti-RhCMV immunoglobulin M (IgM) antibodies within 1 to 2 wpi and IgG antibodies within 2 to 4 wpi against a limited number of viral proteins. Host reactivity to RhCMV proteins increased in titer (total and neutralizing) and avidity with time. These results demonstrate that while antiviral immune responses were able to protect from disease, they were insufficient to eliminate reservoirs of persistent viral gene expression.
Figures
Similar articles
-
Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.J Virol. 2022 Feb 9;96(3):e0165321. doi: 10.1128/JVI.01653-21. Epub 2021 Nov 17. J Virol. 2022. PMID: 34788083 Free PMC article.
-
Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.J Virol. 2002 Aug;76(15):7661-71. doi: 10.1128/jvi.76.15.7661-7671.2002. J Virol. 2002. PMID: 12097580 Free PMC article.
-
Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.J Virol. 2019 Feb 5;93(4):e02077-18. doi: 10.1128/JVI.02077-18. Print 2019 Feb 15. J Virol. 2019. PMID: 30487278 Free PMC article.
-
Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.Adv Virus Res. 2008;72:207-26. doi: 10.1016/S0065-3527(08)00405-3. Adv Virus Res. 2008. PMID: 19081492 Review.
-
Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.Curr Opin Virol. 2017 Aug;25:126-133. doi: 10.1016/j.coviro.2017.08.005. Epub 2017 Sep 6. Curr Opin Virol. 2017. PMID: 28888133 Free PMC article. Review.
Cited by
-
Immune perturbation following SHIV infection is greater in newborn macaques than in infants.JCI Insight. 2024 Aug 27;9(19):e144448. doi: 10.1172/jci.insight.144448. JCI Insight. 2024. PMID: 39190496 Free PMC article.
-
FcRγ- NK Cell Induction by Specific Cytomegalovirus and Expansion by Subclinical Viral Infections in Rhesus Macaques.J Immunol. 2023 Aug 1;211(3):443-452. doi: 10.4049/jimmunol.2200380. J Immunol. 2023. PMID: 37314415 Free PMC article.
-
Modeling of vertical transmission and pathogenesis of cytomegalovirus in pregnancy: Opportunities and challenges.Front Virol. 2023;3:1106634. doi: 10.3389/fviro.2023.1106634. Epub 2023 Feb 3. Front Virol. 2023. PMID: 36908829 Free PMC article.
-
Human Cytomegalovirus Replication and Infection-Induced Syncytia Formation in Labial, Foreskin, and Fetal Lung Fibroblasts.Viruses. 2021 Nov 24;13(12):2355. doi: 10.3390/v13122355. Viruses. 2021. PMID: 34960624 Free PMC article.
-
Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.J Virol. 2022 Feb 9;96(3):e0165321. doi: 10.1128/JVI.01653-21. Epub 2021 Nov 17. J Virol. 2022. PMID: 34788083 Free PMC article.
References
-
- Ahn K, Gruhler A, Galocha B, Jones T R, Wiertz E J, Ploegh H L, Peterson P A, Yang Y, Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 1997;6:613–621. - PubMed
-
- Alcendor D J, Barry P A, Pratt-Lowe E, Luciw P A. Analysis of the rhesus cytomegalovirus immediate-early gene promoter. Virology. 1993;194:815–821. - PubMed
-
- Alford C A, Britt W J. Cytomegalovirus. In: Roizman B, Whitley R J, Lopez C, editors. The human herpesviruses. New York, N.Y: Raven Press; 1993. pp. 227–255.
-
- Andreoni M, Faircloth M, Vugler L, Britt W J. A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods. 1989;23:157–168. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials